For health care professionals
Seattle Cancer Care Alliance (SCCA) is a nationally recognized treatment center that provides advanced therapies and clinical trials for cancers and other blood disorders. SCCA unites the doctors and technology from Fred Hutchinson Cancer Research Center, UW Medicine and Seattle Children's and provides a variety of resources for community doctors and other healthcare professionals.
News from our blog
Treatment for metastatic kidney cancer is evolving rapidly, as providers move away from performing upfront cytoreductive surgery and navigate a growing number of new therapies and combined drug regimens. SCCA’s Kidney Cancer Multispecialty Clinic (KCMC) offers multidisciplinary consultations and care to help community oncologists and their patients understand and access the latest treatment options.
Join our renowned experts from Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center and the University of Washington for the 12th Annual Comprehensive Hematology and Oncology Review Course.
Sarcoma: Innovative approaches are transforming care.
The sarcoma treatment landscape is changing dramatically, with a growing number of FDA-approved drugs and clinical trials offering new hope and improving outcomes for patients whose treatment options were very limited just a few years ago.
CAR T-cell therapy for leukemia and lymphoma patients can be an incredibly effective treatment. That means understanding when to refer a patient for treatment is critical.
Journal of Clinical Investigation: Dr. Stanley Riddell, professor (Medical Oncology) is senior author of “A therapeutic cancer vaccine delivers antigens and adjuvants to lymphoid tissues using genetically modified T cells”
A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors
Investigator: Sylvia M. Lee, MD
A Study to Evaluate the Efficacy and Safety of JCAR017 in Adult Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma (NHL) (TRANSCEND FL)
Investigator: David G. Maloney, MD, PhD
A Study of CART-PSMA-TGFßRDN in Patients With Metastatic Castration Resistant Prostate Cancer
Investigator: Dr. Michael Schweizer
Subscribe to our SCCA/UWMC clinical trial portfolios
- Skin oncology research portfolio: Contact SLMskin@seattlecca.org
- Monthly email communication includes PDF file of available clinical trials organized by disease setting for melanoma and Merkel cell carcinoma
- GU oncology research portfolio: Contact SLMgu@seattlecca.org
- Monthly email communication includes PDF files of available clinical trials organized by disease setting for prostate, bladder and kidney cancer
- Heme and heme malignancies: Subscribe by signing up for Oncology Insights
- Breast, Heme and heme malignancies: Subscribe by signing up for Oncology Insights
Presenters: Petros Grivas, MD, PhD; Evan Y. Yu, MD
Thursday, September 30, 2021 from 6:30pm to 8:00pm PDT